Back to top
more

The Pennant Group (PNTG)

(Real Time Quote from BATS)

$34.70 USD

34.70
54,678

+0.91 (2.69%)

Updated Oct 14, 2024 01:04 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 7% (18 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why You Should Add Elevance Health Stock to Your Portfolio

by Zacks Equity Research

ELV benefits from an increase in employer group fee-based memberships, partially offsetting the impact of Medicaid memberships.

Compelling Reasons to Hold on to Encompass Health Stock Right Now

by Zacks Equity Research

EHC remains well-poised for growth on the back of improved revenues, an extensive rehabilitation hospital network and sufficient cash-generating abilities.

Here is Why Growth Investors Should Buy The Pennant Group (PNTG) Now

by Zacks Equity Research

The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market.

Indrajit Bandyopadhyay headshot

DaVita Stock Rallies 17% in 3 Months: Is it Still Worth Buying?

by Indrajit Bandyopadhyay

DVA stock has the potential to continue its uptrend on the back of better revenues per treatment as well as growth of the overall dialysis market.

Centene's Michigan Unit Partners With Mae to Reduce Health Disparities

by Zacks Equity Research

CNC's Meridian unit collaborates with Mae to improve health outcomes and address health disparities in Michigan.

3 Reasons Why Growth Investors Shouldn't Overlook The Pennant Group (PNTG)

by Zacks Equity Research

The Pennant Group (PNTG) could produce exceptional returns because of its solid growth attributes.

DaVita Inc. (DVA) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Centene's Unit Secures New Four-Year Medicaid Contract in Iowa

by Zacks Equity Research

CNC's unit, Iowa Total Care, wins a new contract to provide Medicaid managed care services, enhancing its presence in Iowa and bringing improved health outcomes in the state.

Is The Pennant Group (PNTG) a Solid Growth Stock? 3 Reasons to Think "Yes"

by Zacks Equity Research

The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market.

DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

The Pennant Group (PNTG) is an Incredible Growth Stock: 3 Reasons Why

by Zacks Equity Research

The Pennant Group (PNTG) could produce exceptional returns because of its solid growth attributes.

Here's What Key Metrics Tell Us About The Pennant Group (PNTG) Q2 Earnings

by Zacks Equity Research

Although the revenue and EPS for The Pennant Group (PNTG) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

The Pennant Group, Inc. (PNTG) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

The Pennant Group (PNTG) delivered earnings and revenue surprises of 14.29% and 7.68%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Addus HomeCare (ADUS) delivered earnings and revenue surprises of 12.50% and 1.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

DGX vs. PNTG: Which Stock Is the Better Value Option?

by Zacks Equity Research

DGX vs. PNTG: Which Stock Is the Better Value Option?

Tenet Healthcare (THC) Gains 89% in a Year: More Room to Run?

by Zacks Equity Research

Tenet Healthcare (THC) is well-poised to gain from improved volumes, expansion of specialty services, streamlining operations and operational efficiency.

DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Centene (CNC) Expands CHS Network, Shifts AcariaHealth Facility

by Zacks Equity Research

Centene's (CNC) subsidiaries, CHS and AcariaHealth, enhance patient outcomes with CHS' CIPA entering Virginia and AcariaHealth's pharmacy facility relocating to Chesterfield, thereby expanding CNC's capabilities.

The Pennant Group, Inc. (PNTG) is a Great Momentum Stock: Should You Buy?

by Zacks Equity Research

Does The Pennant Group, Inc. (PNTG) have what it takes to be a top stock pick for momentum investors? Let's find out.

Here's Why You Should Retain UnitedHealth Group (UNH) Stock

by Zacks Equity Research

UnitedHealth Group (UNH) remains well-poised for growth on the back of a sound customer base, acquisitions and partnerships, the telehealth services suite, and growing cash reserves.

Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and The Pennant Group

by Zacks Equity Research

DaVita, Encompass Health, Option Care Health and The Pennant Group have been highlighted in this Industry Outlook article.

Debanjana Dey headshot

4 Stocks to Buy in a Thriving Outpatient Home Health Industry

by Debanjana Dey

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poised to gain.

The Zacks Analyst Blog Highlights DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant

by Zacks Equity Research

DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant are included in this Analyst Blog.

Nalak Das headshot

Top 5 Outpatient and Home Healthcare Stocks for Solid Returns

by Nalak Das

We have narrowed our search to outpatient and home healthcare stocks that have strong growth potential for 2024. These are: DVA, ADUS, OPCH, EHC, PNTG.

Compared to Estimates, The Pennant Group (PNTG) Q1 Earnings: A Look at Key Metrics

by Zacks Equity Research

The headline numbers for The Pennant Group (PNTG) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.